Not surprisingly, starting from D21 post-injection, AAV-Cre mice exhibited higher levels of plasma ALT (Fig. 2c), whereas markedly elevated levels of plasma bilirubin (Fig. 2c), triglyceride (TG) (Supplemental Fig. S2b), cholesterol (Supplemental Fig. S2c), and hypoglycemia (Supplemental Fig. S2d) were observed until D24 post-injection in these mice compared with AAV-GFP mice. Here, GPT is linked to Hypoglycemia.